Failure of pentavalent antimony in visceral leishmaniasis in India: Report from the center of the Indian epidemic

Clinical Infectious Diseases

Volumn 31, Issue 4, 2000, Pages 1104-1107

  Sundar, Shyam ^a   More, Deepak K ^a   Singh, Manoj K ^a   Singh, Vijay P ^a   Sharma, Sashi ^a   Makharia, Anand ^a   Kumar, Prasanna C K ^a   Murray, Henry W ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b WEILL CORNELL MEDICAL COLLEGE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMONY GLUCONATE;

ADOLESCENT; ADULT; AGED; ARTICLE; CHILD; DRUG EFFICACY; FEMALE; HUMAN; INDIA; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TREATMENT FAILURE; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; AGED; ANTIMONY SODIUM GLUCONATE; ANTIPROTOZOAL AGENTS; CHILD; CHILD, PRESCHOOL; DISEASE OUTBREAKS; FEMALE; HUMANS; INDIA; INFANT; LEISHMANIASIS, VISCERAL; MALE; MIDDLE AGED; TREATMENT FAILURE;

EID: 0034451615     PISSN: 10584838     EISSN: None     Source Type: Journal    
DOI: 10.1086/318121     Document Type: Article

References (19)

1. Kala-azar cases and deaths
2. Epidemiology of visceral leishmaniasis in India
3. Clinicoepidemiological study of drug resistance in Indian kala-azar
4. Do the diminishing efficacy and increasing toxicity of sodium stibogluconate in the treatment of visceral leishmaniasis in Bihar, India, justify its continued use as a first-line drug? An observational study of 80 cases
5. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
6. Response to interferon-γ plus pentavalent antimony in Indian visceral leishmaniasis
7. Randomised controlled trial of aminosidine (paromomycin) v. Sodium stibogluconate for treating visceral leishmaniasis in North Bihar, India
8. Recommendations for treating leishmaniasis with sodium stibogluconate (Pentostam) and review of pertinent clinical studies
9. Treatment of antimony-unresponsive Indian visceral leishmaniasis with ultra-short courses of amphotericin-B-lipid complex
10. Resistance to treatment in kala-azar: Speciation of isolates from northeast India
11. US Food and Drug Adminstration approval of AmBisome (liposomal amphotericin B) for treatment of visceral leishmaniasis
12. Oral treatment of visceral leishmaniasis with miltefosine
13. Efficacy of sodium antimony gluconate and ketoconazole in the treatment of kala-azar: A comparative study
14. Leishmaniasis
15. Evidence that the high incidence of treatment failure in Indian kala-azar is due to the emergence of antimony-resistant strains of Leishmania donovani
16. Leishmania and human immunodeficiency virus coinfection: The first 10 years
17. Clarification of comments on trial of aminosidine in visceral leishmaniasis
18. Use of the polymerase chain reaction to assess the success of visceral leishmaniasis treatment
19. Recent advances in tropical medicine